CK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

UNDATED (WKRC) - Weight-loss medications may not be as effective in "real-world" settings as they are in clinical trials, ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7% on average.

New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

As wearable ECG technology advances, cardiac safety studies in clinical trials are evolving to capture richer, continuous ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

It’s been over two years since The Resident was canceled after six seasons on Fox, a decision that came months after the ...